摘要
与更传统的系统方法相比,采用分子技术的靶标发现需要对身体状况或疾病隐藏下的胞内或生物学过程进行研究。实验室科学家使用的方法可能是遗传的、基因组的或蛋白质组学的,每种方法在药物靶标发现中都有其一席之地。应用于药物发现以亲和力为基础的蛋白组学技术可供利用于若干原理、合成化学、细胞生物、生物化学和质谱分析。 探针是该技术的重要组件,它是专门设计以便在细胞裂解液中从成千上万的多变蛋白中挑选一个或成套蛋白。第二主要组成部分是高效液相色谱-串联质谱(LC-MS/MS),LC-MS/MS 和辅助的理论框架已经成熟,可作为蛋白定性和定量选择的工具。在药物发现更广泛的大背景下,这些蛋白组学工具是坚持供应候选药物的关键。
关键词: 亲和纯化,药物靶标发现,固定,质谱分析法,探针,定量
Current Drug Targets
Title:Affinity-Based Methods in Drug-Target Discovery
Volume: 16 Issue: 1
Author(s): Gabriela Rylova, Tomas Ozdian, Lakshman Varanasi, Miroslav Soural, Jan Hlavac, Dusan Holub, Petr Dzubak and Marian Hajduch
Affiliation:
关键词: 亲和纯化,药物靶标发现,固定,质谱分析法,探针,定量
摘要: Target discovery using the molecular approach, as opposed to the more traditional systems approach requires the study of the cellular or biological process underlying a condition or disease. The approaches that are employed by the “bench” scientist may be genetic, genomic or proteomic and each has its rightful place in the drug-target discovery process. Affinity-based proteomic techniques currently used in drug-discovery draw upon several disciplines, synthetic chemistry, cell-biology, biochemistry and mass spectrometry. An important component of such techniques is the probe that is specifically designed to pick out a protein or set of proteins from amongst the varied thousands in a cell lysate. A second component, that is just as important, is liquid-chromatography tandem massspectrometry (LC-MS/MS). LC-MS/MS and the supporting theoretical framework has come of age and is the tool of choice for protein identification and quantification. These proteomic tools are critical to maintaining the drug-candidate supply, in the larger context of drug discovery.
Export Options
About this article
Cite this article as:
Gabriela Rylova, Tomas Ozdian, Lakshman Varanasi, Miroslav Soural, Jan Hlavac, Dusan Holub, Petr Dzubak and Marian Hajduch , Affinity-Based Methods in Drug-Target Discovery, Current Drug Targets 2015; 16 (1) . https://dx.doi.org/10.2174/1389450115666141120110323
DOI https://dx.doi.org/10.2174/1389450115666141120110323 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics Curcuminoid Metabolism and its Contribution to the Pharmacological Effects
Current Drug Metabolism Pharmacogenomics: The Influence of Genomic Variation on Drug Response
Current Topics in Medicinal Chemistry Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Current Pharmaceutical Biotechnology Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets 18F-fluoro-deoxy-D-glucose PET/CT in Establishing the Relationship Between the Metabolic Activity of Aorta and Iliac Artery Aneurysms in Cancer Patients
Current Medical Imaging MMPs in Ovarian Cancer as Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Characterization and Immunological Evaluation of Low-Molecular- Weight Alginate Derivatives
Current Topics in Medicinal Chemistry Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) The Potential of Statins for Individualized Colorectal Cancer Chemoprevention
Current Drug Targets Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer
Current Pharmaceutical Design Physiological Functions of Presenilins; Beyond γ-Secretase
Current Pharmaceutical Biotechnology Cholangiocarcinoma Therapeutics: An Update
Current Cancer Drug Targets Formulation Development and Characterization of Guar Gum Microspheres for Colon Delivery
Nanoscience & Nanotechnology-Asia Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Endocrine, Metabolic & Immune Disorders - Drug Targets Rectal Cancer in Patients Younger than 40: Tumor Characteristics and Comparative Survival Based on a Single Institution
Current Cancer Therapy Reviews Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia
Current Cancer Drug Targets Phenolic Compounds: the Role of Redox Regulation in Neurodegenerative Disease and Cancer
Mini-Reviews in Medicinal Chemistry Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators
Current Cancer Drug Targets